|Articles|January 15, 2002

BioPharm International

  • BioPharm International-01-01-2002
  • Volume 15
  • Issue 1

Inside Washington: Biotechnology in the Limelight, the Year Ahead

Author(s)Jill Wechsler

by Jill Wechsler Continued concerns about bioterrorism will shape legislative and regulatory initiatives affecting biotech manufactures.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

about 24 years ago

Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaboration

about 24 years ago

Your Vested Interests: The War of the West

about 24 years ago

Statistics for Laboratory Method Comparison Studies

about 24 years ago

From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continues

about 24 years ago

Systematic Troubleshooting for LC/MS/MS: Part 2, Large-Scale LC/MS/MS and Automation

about 24 years ago

Liposomes (a Review): Part Two, Drug Delivery Systems

about 24 years ago

Information Age Audits

about 25 years ago

Considerations During Development of a Protein A-Based Antibody Purification Process

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!